Dulanermin (USAN/INN)

C871H1329N243O260S4

19480.7125

19492.61

Val Arg Glu Arg Gly Pro Gln Arg Val Ala Ala His Ile Thr Gly Thr
Arg Gly Arg Ser Asn Thr Leu Ser Ser Pro Asn Ser Lys Asn Glu Lys
Ala Leu Gly Arg Lys Ile Asn Ser Trp Glu Ser Ser Arg Ser Gly His
Ser Glu Leu Ser Asn Leu His Leu Arg Asn Gly Glu Leu Val Ile His
Glu Lys Gly Phe Tyr Tyr Glu Glu Ile Lys Glu Asn Thr Lys Asn Asp
Lys Gln Met Val Gln Tyr Ile Tyr Lys Tyr Thr Ser Tyr Pro Asp Pro
Ile Leu Leu Met Lys Ser Ala Arg Asn Ser Cys Trp Ser Lys Asp Ala
Glu Tyr Gly Leu Tyr Ser Ile Tyr Gln Gly Gly Ile Phe Glu Leu Lys
Glu Asn Asp Arg Ile Phe Val Ser Val Thr Asn Glu His Leu Ile Asp
Met Asp His Glu Ala Ser Phe Phe Gly Ala Phe Leu Val Gly

Antineoplastic

recombinant human Apo2L/TRAIL [HSA:8743] [KO:K04721]
Treatment of metastatic non-small cell lung cancer